Evidence map›Paper›PMID 41800503›Full record

ArticleThe Canadian journal of urology2026

Suprapubic transvesical adenoma resection of the prostate (STAR-P): step-by-step technique.

Christian Gozzi, Bruno Bucca, Orietta Dalpiaz, Aldo Brassetti, Luca Matteo Gobbi, Greta Basile, Miroslav Djordjevic

Abstract read
PubMed Publisher
In one paragraph

Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christian GozziCity Clinic, Urology, Bozen, 39100, Italy.
Bruno BuccaUrology Department, Università La Sapienza, Rome, 00185, Italy.
Orietta DalpiazUrology Department, Klinikum Klagenfurt, 9020, Austria.
Aldo BrassettiUrology Department, IRCCS "Regina Elena" National Cancer Institute, Rome, 00128, Italy.
Luca Matteo GobbiUrology Department, Università La Sapienza, Rome, 00185, Italy.
Greta BasileUrology Department, Università La Sapienza, Rome, 00185, Italy.
Miroslav DjordjevicBelgrade Center for Genitourinary Reconstructive Surgery, Serbia, 11000, Belgrade.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

overviewSurgical management of benign prostatic hyperplasia (BPH) has evolved significantly, incorporating various minimally invasive procedures aimed at reducing morbidity and optimizing patient outcomes. Despite advancements, transurethral approaches continue to pose risks such as urethral strictures and urinary incontinence due to mechanical and thermal stress. To address these limitations, the Suprapubic Transvesical Adenoma Resection of the Prostate (STAR-P) was developed, offering a direct suprapubic route that bypasses the urethra entirely. Recent studies have validated STAR-P as both feasible and safe, emphasizing advantages such as enhanced visualization of the urinary sphincter, minimized urethral trauma, effective hemostasis, and reduced operative stress. The procedure utilizes specially designed instrumentation, including a large-caliber bipolar resectoscope (42 Fr), allowing the efficient removal of substantial adenoma tissue in fewer resection passes compared to traditional methods.

objectivesThis article provides a comprehensive, step-by-step description of the STAR-P technique. The primary objective is to detail patient selection criteria, preoperative assessments, procedural steps including mini-open suprapubic access, specialized instrumentation usage, resection techniques, and postoperative management protocols. Highlighting technical considerations and procedural innovations aims to inform urologists about the potential benefits of STAR-P, particularly in patients at higher risk for urethral complications or those with large prostate volumes. By documenting the procedural intricacies and outcomes clearly and thoroughly, we seek to encourage informed adoption of STAR-P as an alternative, effective surgical approach for managing benign prostatic hyperplasia, thus contributing to the evolving landscape of minimally invasive urological surgery.

Indexed as

ProstatectomyProstatic HyperplasiaHumansMalePatient SelectionRetrospective Studiesbenign prostatic hyperplasiabladder outlet obstructionfunctional urologylower urinary tract symptomsprostate surgery

Identifiers

PMID41800503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.